ABL Bio has ranked among the top searched stocks for 12 days in the past month.

As of 1:30 PM on the 24th, ABL Bio is trading at 34,350 KRW, down 6.28% from the previous day. This represents an 88.74% increase compared to May 27. ABL Bio is known as a specialized company developing bio-pharmaceuticals based on antibody therapeutics.

Today, foreigners have a provisional net purchase of 43,000 shares of ABL Bio, while institutions have a net sale of 108,000 shares. Over the past five days, individual investors have net purchased 341,849 shares, while foreigners and institutions have net sold 258,604 shares and net purchased 18,257 shares, respectively.

On June 16, ABL Bio was a market topic with the headline "Benefiting from SK Biopharm's IPO... Discussing technology transfers with 15 big pharma companies."



[Table] Foreigners and Institutions Net Trading Volume (Unit: shares)
※Source: AI Investment Assistant AI Rassiro

※ This article was generated in real-time by an automated article creation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.



This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing